Sage Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Sage Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sage Capital Management from 13F filings

Historical chart of Sage Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sage Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sage Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $214k 472 453.36
2025-06-30 $210k 472 445.20
2025-03-31 $229k 472 484.82
2024-09-30 $220k 472 465.08
2024-06-30 $221k 472 468.72

More positions owned by Sage Capital Management

NVIDIA Corporation (NVDA)
Global X Fds Us Infr Dev Etf (PAVE)
Select Sector Spdr Tr State Street Tec (XLK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Ea Series Trust Strive 500 Etf (STRV)
Amplify Etf Tr Amplify Cybersec (HACK)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr State Street Con (XLP)
Spdr Series Trust State Street Spd (CWB)
International Business Machines (IBM)
Wisdomtree Tr Us Midcap Divid (DON)
Spdr Series Trust State Street Spd (XITK)
Nuveen Equity Premium Income Fund (BXMX)

View all positions for Sage Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
FMR
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated